XML 36 R6.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Related Party
Nonrelated Party
Warrants Issued, Debt Offering
Warrants Issued, Equity Offering
Series A Preferred Stock
Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Common Stock
Related Party
Common Stock
Nonrelated Party
Additional Paid-in Capital
Additional Paid-in Capital
Related Party
Additional Paid-in Capital
Nonrelated Party
Additional Paid-in Capital
Warrants Issued, Debt Offering
Additional Paid-in Capital
Warrants Issued, Equity Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021             0   99,976,253                
Beginning balance at Dec. 31, 2021 $ 123,179           $ 0   $ 100     $ 218,762         $ (95,683)
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)               9,566                  
Convertible promissory notes converted to common stock           $ 9,273   $ 9,273                  
Warrant issuances in conjunction with equity offerings       $ 8,315 $ 5,700                   $ 8,315 $ 5,700  
Stock-based compensation expense $ 1,568                     1,568          
Warrant exercise (in shares) 5,714,823               5,714,823                
Warrant exercise $ 58               $ 6     52          
Modifications to embedded conversion feature of convertible promissory notes 1,592                     1,592          
Issuance of common stock, net of issuance costs (in shares)                 39,801,895                
Issuance of common stock, net of issuance costs 58,860               $ 39     58,821          
Net loss (90,791)                               (90,791)
Ending balance (in shares) at Dec. 31, 2022             9,566   145,492,971                
Ending balance at Dec. 31, 2022 117,754           $ 9,273   $ 145     294,810         (186,474)
Common stock reacquired in exchange for warrants (in shares)                 (12,000,000)                
Common stock reacquired in exchange for warrants (12,491)               $ (12)     (12,479)          
Warrant issuance in conjunction with debt modification 16,036                     16,036          
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)                 11,762,956                
Convertible promissory notes converted to common stock 4,705               $ 12     4,693          
Warrant issuances in conjunction with equity offerings $ 14,991                     14,991          
Warrant exercise (in shares) 2,740,587               25,871,539                
Warrant exercise $ 3,527               $ 27     3,500          
Issuance of common stock, net of issuance costs (in shares)                 99,136,670                
Issuance of common stock, net of issuance costs $ 132,542               $ 98     132,444          
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)                   2,460,513 5,586,736            
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock   $ 15,000 $ 5,859             $ 2 $ 5   $ 14,998 $ 5,854      
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (1,578,056)               (1,578,056)                
Tax withholdings related to net share settlements of stock-based compensation awards $ (2,013)                     (2,013)          
Net loss (73,421)                               (73,421)
Ending balance (in shares) at Dec. 31, 2023             9,566   276,733,329                
Ending balance at Dec. 31, 2023 $ 222,489           $ 9,273   $ 277     $ 472,834         $ (259,895)